Table 1.
Characteristics of the study population
| Age 70 (303–306 observations) | Age 75 (269–298 observations) | ||
|---|---|---|---|
| Variable | Mean ± SD | Mean ± SD | Units |
| SBP | 148·97 ± 22·27 | 148·03 ± 19·28 | mmHg |
| DBP | 78·22 ± 9·98 | 75·74 ± 9·94 | mmHg |
| Fasting blood glucose | 5·34 ± 1·58 | 5·38 ± 1·47 | mmol l−1 |
| Anti-HT med | 33 | 50 | % |
| MI | 7 | 8 | % |
| Stroke | 4 | 10 | % |
| Diabetes | 11 | 13 | % |
| β-Blockers | 19 | 28 | % |
| Statins | 13 | 26 | % |
| Smoker | 8 | 5 | % |
| Total cholesterol | 5·37 ± 0·96 | 5·39 ± 1·09 | mmol l−1 |
| HDL cholesterol | 1·48 ± 0·37 | 1·41 ± 0·40 | mmol l−1 |
| Serum triglycerides | 1·31 ± 0·63 | 1·38 ± 0·63 | mmol l−1 |
| BMI | 26·87 ± 4·06 | 26·54 ± 4·08 | kg m−2 |
SBP, systolic blood pressure; DBP, diastolic blood pressure; Anti-HT med, antihypertensive medication; MI, myocardial infarction; HDL, high-density lipoprotein; BMI, body mass index.